Serum amyloid P component binds to cell nuclei in vitro and to in vivo deposits of extracellular chromatin in systemic lupus erythematosus - PubMed (original) (raw)
Serum amyloid P component binds to cell nuclei in vitro and to in vivo deposits of extracellular chromatin in systemic lupus erythematosus
S M Breathnach et al. J Exp Med. 1989.
Abstract
Serum amyloid P component (SAP) is the single plasma protein that, from the milieu of whole normal human serum, undergoes specific calcium-dependent binding to isolated DNA and chromatin in vitro. We now report for the first time that SAP in whole serum also undergoes calcium-dependent binding to nuclei of epidermal cells in sections of normal human skin and to nuclei of fixed Hep-2 cells, a human epithelial cell line. Furthermore, and most importantly, SAP was detected in association with unusual globular dermal deposits of nuclear material in skin biopsies from two patients with systemic lupus erythematosus. This is the first evidence for binding of SAP to extracellular chromatin in vivo and supports the idea that SAP may have an important physiological role in the disposal of this material.
Similar articles
- Binding of pentraxins to different nuclear structures: C-reactive protein binds to small nuclear ribonucleoprotein particles, serum amyloid P component binds to chromatin and nucleoli.
Pepys MB, Booth SE, Tennent GA, Butler PJ, Williams DG. Pepys MB, et al. Clin Exp Immunol. 1994 Jul;97(1):152-7. doi: 10.1111/j.1365-2249.1994.tb06594.x. Clin Exp Immunol. 1994. PMID: 8033412 Free PMC article. - Complexes of serum amyloid P component and DNA in serum from healthy individuals and systemic lupus erythematosus patients.
Sørensen IJ, Holm Nielsen E, Schrøder L, Voss A, Horváth L, Svehag SE. Sørensen IJ, et al. J Clin Immunol. 2000 Nov;20(6):408-15. doi: 10.1023/a:1026478914129. J Clin Immunol. 2000. PMID: 11202230 - Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity.
Bickerstaff MC, Botto M, Hutchinson WL, Herbert J, Tennent GA, Bybee A, Mitchell DA, Cook HT, Butler PJ, Walport MJ, Pepys MB. Bickerstaff MC, et al. Nat Med. 1999 Jun;5(6):694-7. doi: 10.1038/9544. Nat Med. 1999. PMID: 10371509 - [Amyloid P components in normal human skin and skin with lesions].
Hintner H, Breathnach SM. Hintner H, et al. Hautarzt. 1988 Nov;39(11):712-6. Hautarzt. 1988. PMID: 3072321 Review. German.
Cited by
- Genetic evidence for serum amyloid P component as a drug target in neurodegenerative disorders.
Schmidt AF, Finan C, Chopade S, Ellmerich S, Rossor MN, Hingorani AD, Pepys MB. Schmidt AF, et al. Open Biol. 2024 Jul;14(7):230419. doi: 10.1098/rsob.230419. Epub 2024 Jul 17. Open Biol. 2024. PMID: 39013416 Free PMC article. - Development of a Cell-based Neutralizing Antibody Assay for Zinpentraxin Alfa: Challenges and Mitigation Strategies.
Yin Z, Guerrero J, Melendez R, Andrews B, Peng K. Yin Z, et al. AAPS J. 2023 Jul 20;25(5):75. doi: 10.1208/s12248-023-00841-2. AAPS J. 2023. PMID: 37468730 - TMT-Based Proteomic Analysis of Human Spermatozoa from Unexplained Recurrent Miscarriage Patients before and after Oral Antioxidant Treatment.
Fernandez-Encinas A, Ribas-Maynou J, García-Peiró A, Garcia-Segura S, Martinez-Pasarell O, Navarro J, Oliver-Bonet M, Benet J. Fernandez-Encinas A, et al. Biomedicines. 2022 Aug 19;10(8):2014. doi: 10.3390/biomedicines10082014. Biomedicines. 2022. PMID: 36009561 Free PMC article. - The Pentraxins 1975-2018: Serendipity, Diagnostics and Drugs.
Pepys MB. Pepys MB. Front Immunol. 2018 Oct 16;9:2382. doi: 10.3389/fimmu.2018.02382. eCollection 2018. Front Immunol. 2018. PMID: 30459761 Free PMC article. Review. - Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis.
Mistry P, Kaplan MJ. Mistry P, et al. Clin Immunol. 2017 Dec;185:59-73. doi: 10.1016/j.clim.2016.08.010. Epub 2016 Aug 9. Clin Immunol. 2017. PMID: 27519955 Free PMC article. Review.
References
- Arthritis Rheum. 1973 Sep-Oct;16(5):579-89 - PubMed
- J Invest Dermatol. 1975 Jul;65(1):154-61 - PubMed
- Clin Exp Immunol. 1979 Nov;38(2):284-93 - PubMed
- J Exp Med. 1980 Nov 1;152(5):1162-74 - PubMed
- J Exp Med. 1981 Oct 1;154(4):1134-9 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous